Diabetic retinopathy following solid-organ pancreas transplant

• Research type

  Research Study

• Full title

  Diabetic retinopathy following solid-organ pancreas transplant: implications for service provision

• IRAS ID

  275236

• Contact name

  Maria Francesca Cordeiro

• Contact email

  francesca.cordeiro@nhs.net

• Duration of Study in the UK

  0 years, 3 months, 0 days

• Research summary

  Diabetic retinopathy (DR) is the most common microvascular complication of diabetes mellitus (DM) and a leading cause of preventable blindness in the developed world. It affects approximately 95 million people worldwide. The prevalence of DM is increasing and is estimated to affect 592 million people by 2035. The rise in patient numbers necessitates continual improvement in monitoring for diabetic complications.
  Pancreatic transplants can restore normal blood sugar levels and are therefore a useful treatment. However, the data examining the stability of diabetic eye disease following transplant remains limited.

  The aims of this study are to investigate the changes of diabetic eye disease in patients undergoing pancreatic transplant, and the stability of diabetic eye disease and visual function following pancreatic transplant. This will have important implications on how such patients are detected and followed up by ophthalmology services.

• REC name

  N/A

• REC reference

  N/A